Haplo-cord HCT offered improved 2-year OS (72.7% vs 61.0%) and DFS (67.0% vs 49.6%) compared with haplo HCT alone.
The Mid Valley community is mourning the loss of 20-year-old Eddie Kauffman, a beloved athlete, friend, and inspiration whose ...
Eddie Kaufman played hard on the field, but fought even harder off the diamond before losing his fight with leukemia at the ...
Mid Valley High School grad Eddie Kaufman, a star on the baseball field and golf course, and among family and friends, died ...
SOUTH SAN FRANCISCO, Calif., and NEW HAVEN, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Simcha Therapeutics (“Simcha”), a clinical-stage ...
Roanoke student and baseball player Eddie Kaufman passed Tuesday after a courageous battle with T-cell acute lymphoblastic leukemia, the Roanoke College Athletics Facebook page has reported.
Clinicopathologic Characteristics and Survival Outcome of Patients With Mantle Cell Lymphoma: A North Indian Tertiary Care Center Experience Acute leukemia is a group of hematologic malignancies ...
October 12, 2025 - PORTERVILLE, Calif. — A cutting-edge cancer treatment that reprograms the body’s own immune cells saved a ...
Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.